FindTrial
Sign In

Should node stage be replaced by lymph node ratio among radically-resected cases with biliary tract cancers? A SEER-based retrospective cohort study and a prognostic nomogram.

Should node stage be replaced by lymph node ratio among radically-resected cases with biliary tract cancers? A SEER-based retrospective cohort study and a prognostic nomogram.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080210
Enrollment
Unknown
Registered
2024-01-23
Start date
2024-01-25
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary track cancer

Interventions

Training group:None
Validation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: resected cases with biliary tract cancers

Exclusion criteria

Exclusion criteria: Cases who failed to received curative surgery, cases without adequate surgery-related data, cases without adequate survival information, or cases without required clinical data.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
The predictive accuracy of model;—

Countries

China

Contacts

Public ContactLi Fuyu

West China Hospital of Sichuan University

lfy_74@hotmail.com+86 189 8060 1862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026